BioNexus Gene Lab Ownership | Who Owns BioNexus Gene Lab?
BioNexus Gene Lab Ownership Summary
BioNexus Gene Lab is owned by 0.01% institutional investors, 35.59% insiders, and 64.40% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.10% of its assets in BioNexus Gene Lab shares.
BGLC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioNexus Gene Lab | 0.01% | 35.59% | 64.40% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Diagnostics & Research Stocks | 50.92% | 10.77% | 38.30% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 2 | 100.00% | 232 | -99.51% | - | 0.14% | 2 | 100.00% | - | - |
| Dec 31, 2025 | 1 | -50.00% | 47,830 | 114.71% | 2 | 167.55% | 1 | - | - | -100.00% |
| Sep 30, 2025 | 2 | 100.00% | 22,277 | 132.97% | 1 | 437.75% | 1 | - | 1 | - |
| Jun 30, 2025 | 1 | - | 9,562 | - | - | - | 1 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Nasdaq Composite Index | 2.37K | 0.10% | - |
| Blackstone Alternative Multi-Strategy I | 3.00 | 0.00% | - |
BGLC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools